Local Ablative Therapies
Showing 1 - 25 of >10,000
Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)
Recruiting
- Adenocarcinoma
- +8 more
- Radiotherapy targeted to the primary lesion
- +7 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 7, 2023
Colorectal Cancer, Oligometastatic Disease Trial in Australia (Local Ablative Therapy, Standard first-line systemic treatment)
Recruiting
- Colorectal Cancer
- Oligometastatic Disease
- Local Ablative Therapy
- Standard first-line systemic treatment
-
Albury, New South Wales, Australia
- +8 more
May 15, 2023
Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)
Recruiting
- Prostate Cancer
- +3 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Breast Cancer
- +4 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
NSCLC, Oligoprogressive, Small-cell Lung Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Non-small Cell Lung Cancer
- +2 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 27, 2023
Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Esophageal Cancer
- +10 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 27, 2023
Lung Adenocarcinoma, Lung Tumors Trial run by the NCI (osimertinib, LAT)
Completed
- Lung Adenocarcinoma
- Lung Neoplasms
- osimertinib
- LAT
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 17, 2022
Prostate Cancer Trial in Dallas (Ablative Therapy)
Not yet recruiting
- Prostate Cancer
- Ablative Therapy
-
Dallas, TexasUTSW
Jul 25, 2022
Renal Cancer Trial in Calgary, Edmonton
Recruiting
- Renal Cancer
-
Calgary, Alberta, Canada
- +1 more
Apr 5, 2022
NSCLC (NSCLC), Stage IV Trial in Switzerland (Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy),
Not yet recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Stage IV
- Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy)
- +2 more
-
Aarau, Switzerland
- +7 more
Oct 27, 2023
Breast Cancer Invasive, Metastatic Cancer, Oligoprogressive Trial in Amsterdam (procedure, radiation, other)
Not yet recruiting
- Breast Cancer Invasive
- +2 more
- Surgery
- +2 more
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek
Mar 21, 2022
NSCLC, Metastatic Non Small Cell Lung Cancer, Nsclc Trial in United States (Local ablative therapy, Blood collection to assess
Recruiting
- Non-small Cell Lung Cancer
- +5 more
- Local ablative therapy
- Blood collection to assess for ctDNA
-
Basking Ridge, New Jersey
- +6 more
Jun 20, 2022
Biliary Tract Tumors, Liver Cancer, Hepatocellular Carcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Trans-arterial
Active, not recruiting
- Biliary Tract Neoplasms
- +4 more
- Durvalumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 1, 2022
Brain Metastases, Adult Trial in Leuven (Stereotactic radiotherapy)
Recruiting
- Brain Metastases, Adult
- Stereotactic radiotherapy
-
Leuven, BelgiumUZLeuven
Oct 21, 2021
Prostate Cancer Metastatic Trial in Canada (Ablative Radiation Therapy, Standard of care)
Recruiting
- Prostate Cancer Metastatic
- Ablative Radiation Therapy
- Standard of care
-
Victoria, British Columbia, Canada
- +14 more
Nov 14, 2022
Locally Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer Trial in France (SRT, Immunotherapy)
Recruiting
- Locally Advanced Non Small Cell Lung Cancer
- Metastatic Non Small Cell Lung Cancer
- SRT
- Immunotherapy
-
Angers, France
- +4 more
Apr 21, 2022
Oligometastatic Disease, Prostatic Cancer, Castration-Resistant Trial in Dresden (local ablative radiotherapy)
Recruiting
- Oligometastatic Disease
- Prostatic Cancer, Castration-Resistant
- local ablative radiotherapy
-
Dresden, Saxony, GermanyDepartment of Radiotherapy and Radiation Oncology, Faculty of Me
Aug 18, 2021
Colorectal Cancer, Adjuvant Chemo Trial in Guangzhou (wait and watch, adjuvant chemo)
Recruiting
- Colorectal Cancer
- Adjuvant Chemotherapy
- wait and watch
- adjuvant chemotherapy
-
Guangzhou, Guangdong, ChinaSixth Affiliated Hospital of Sun Yat-sen University
Jan 25, 2022
Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)
Not yet recruiting
- Gastric Cancer
- RC48-ADC
- +4 more
-
Beijing, ChinaBeijing Cancer Hospital
Aug 7, 2023
NSCLC With Mutation in Epidermal Growth Factor Receptor Trial in Leuven (Local ablative therapy)
Recruiting
- Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
- Local ablative therapy
-
Leuven, BelgiumUZLeuven
Oct 21, 2021
Advanced Gastric Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Relatlimab)
Active, not recruiting
- Advanced Gastric Cancer
- Nivolumab
- +4 more
-
Phoenix, Arizona
- +34 more
Aug 18, 2022
CirculAting Tumor DNA in Patients DIagnosed With Lung Metastasis
Not yet recruiting
- Colorectal Cancer
- Lung Metastases
- Diagnostic Test: liquid biopsy
-
Seoul, Korea, Republic ofDepartment of Laboratory Medicine, Yonsei University College of
Jan 11, 2021
Post Prostatectomy Trial in Toronto ([18F]DCFPyL PET/MRI scan, Stereotactic Ablative Radiotherapy)
Recruiting
- Post Prostatectomy
- [18F]DCFPyL PET/MRI scan
- Stereotactic Ablative Radiotherapy
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Dec 31, 2021
Carcinoma, NSCLC Trial in Worldwide (nivolumab, ipilimumab, cabozantinib)
Withdrawn
- Carcinoma, Non-small Cell Lung Cancer
- nivolumab
- +5 more
-
Detroit, Michigan
- +22 more
Mar 8, 2022